Hereditary Cancer: An Alarming Trend in India
India reports over 1.4 million new cancer cases annually, with a significant proportion linked to genetic predispositions. According to Dr. Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services at HCG Manavata Cancer Centre, hereditary cancers—such as breast, ovarian, and colorectal cancers—pose a considerable threat to public health, given the 5-10% increased risk faced by individuals with a family history of these cancers.

“A large portion of our population is unaware of their genetic predispositions to certain cancers, missing opportunities for early diagnosis and intervention,” says Dr. Nagarkar.

In this context, patient-centricity means recognizing each individual’s unique risk profile and ensuring that care is tailored to meet their specific needs, from genetic screening to preventive lifestyle counseling. The focus is not just on treating the disease but on empowering patients with the knowledge and resources to take control of their health before cancer even develops.

The Vital Role of Early Detection in Patient-Centered Care
Early detection is crucial in a patient-centric healthcare model, particularly in hereditary cancers. Research shows that detecting cancer in its early stages can drastically improve patient outcomes, with survival rates as high as 99% for breast cancer patients when diagnosed early, compared to 27% in later stages.

“By diagnosing cancer early, we not only increase the likelihood of successful treatment, but we also reduce the invasiveness of procedures and the associated costs,” Dr. Nagarkar adds. “At Vansham Clinic, our aim is to provide at-risk individuals with the necessary tools to prioritize their health. Our approach to care is patient-centered, offering personalized early detection strategies that can ultimately save lives.”

This emphasis on early intervention reflects a commitment to patient-centricity—treating each patient as a unique individual and designing their care journey around their specific risk factors, preferences, and needs.

Enhancing Cancer Care for a Healthier Tomorrow
HCG Manavata Cancer Centre has established itself as a leader in multidisciplinary, patient-focused cancer care. Since its inception, the center has performed over 65,000 surgeries, including 1,100 robotic-assisted procedures, with a dedicated team of 50 oncologists and 900 staff members. The launch of Vansham Clinic further underscores HCGMCC’s commitment to preventive oncology, where personalized care, early intervention, and genetic insights play a crucial role in battling cancer.

“Vansham Clinic is a testament to our belief that addressing hereditary cancer risk requires an informed, personalized approach,” says Dr. Nagarkar. “We want to ensure that every patient has access to the preventive care they deserve, backed by the latest advancements in genetic testing and oncology.”

This approach aligns with patient-centric care, where the focus shifts from reactive treatments to proactive, personalized prevention plans, ensuring that each patient’s journey is uniquely tailored to maximize outcomes.

Vansham Clinic: Prioritizing Patient-Centric Preventive Care
In response to the rising incidence of hereditary cancers in India, HCG Manavata Cancer Centre (HCGMCC) has launched the Vansham Clinic. This specialized clinic aims to tackle the growing need for hereditary cancer awareness and early intervention, providing patients with targeted screenings, genetic counseling, and personalized treatment plans.

The Vansham Clinic epitomizes patient-centricity by offering individualized care to those with a family history of cancer. By focusing on each patient’s genetic makeup and providing tailored, proactive healthcare solutions, the clinic ensures that care is both personalized and preventive, empowering patients to make informed decisions about their health.

A Holistic, Patient-Focused Approach
The Vansham Clinic brings together a team of oncologists, genetic counselors, and healthcare professionals to deliver a holistic, patient-centric model for hereditary cancer screening and prevention. By offering comprehensive genetic testing and family-based screenings, the clinic ensures that individuals with a predisposition to hereditary cancers receive the targeted, proactive care they need.

“At Vansham Clinic, we aim to bridge the knowledge gap by offering advanced genetic counseling, hereditary screenings, and tailored healthcare solutions to empower patients,” explains Dr. Nagarkar. “Our team focuses on long-term follow-up care, ensuring that each patient receives ongoing surveillance and personalized preventive strategies based on their unique genetic risk.”

Also Read: Temasek Holdings Set to Acquire Peak XV’s Stake in Cloudnine Hospitals

About HCG Manavata Cancer Centre (HCGMCC)
Founded by Dr. Raj Nagarkar in 2007, HCG Manavata Cancer Centre is Nashik’s leading cancer treatment facility and the first NABH-accredited hospital in Central India. With a 275-bed capacity, a multidisciplinary team, and cutting-edge technology, HCGMCC offers specialized care across surgical, radiation, and medical oncology.

The launch of Vansham Clinic marks a significant step forward in HCGMCC’s mission to combat hereditary cancer through a patient-centric approach—one that prioritizes prevention, early detection, and personalized care, ultimately working toward a cancer-free future.

This article is attributed to Dr. Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services, HCG Manavata Cancer Centre (HCGMCC), who is pioneering the fight against hereditary cancers through a patient-first approach to awareness, education, and advanced healthcare interventions.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.